Efficacy acebutolol acute myocardial infarction APSI trial APSI randomized placebo-controlled trial effectiveness acebutolol late death high-risk patients acute myocardial infarction MI average mortality rate placebo groups trials beta blockers post-MI patients nonselected cohort patients days MI mandate trial fact high-risk patients mortality rate significant numbers previous trials beta-blocking therapy patient population beneficial Selection high-risk patients inclusion trial algorithm Essai Prevention Secondaire Myocarde Registry time second interim analysis mortality rate placebo group equal trial time patients patients therapy days deaths acebutolol-treated group placebo group reduction total mortality vascular deaths placebo group acebutolol group cardiovascular mortality acebutolol incidence cardiovascular-related deaths acebutolol-treated group total reduction mortality secondary risk factors 